Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1998-04-24
2000-12-12
Weber, Jon P.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
A61K 3848
Patent
active
061594687
ABSTRACT:
The present invention relates to pharmaceutical formulations of activated protein C which also comprises sucrose, sodium chloride and sodium citrate buffer at a pH between about 5.5 and about 6.5. The activated protein C formulations of the present invention are more stable than other formulations of activated protein C and demonstrate fewer degradation products over time.
REFERENCES:
patent: 4775624 (1988-10-01), Bang et al.
patent: 4877608 (1989-10-01), Lee et al.
patent: 4981952 (1991-01-01), Yan
patent: 4992373 (1991-02-01), Bang et al.
patent: 5084273 (1992-01-01), Hirahara
patent: 5093117 (1992-03-01), Lawrence et al.
patent: 5175087 (1992-12-01), Ranby et al.
patent: 5395923 (1995-03-01), Bui-Khac et al.
patent: 5413732 (1995-05-01), Buhl et al.
patent: 5442064 (1995-08-01), Pieper et al.
patent: 5478558 (1995-12-01), Eibl et al.
patent: 5831025 (1998-11-01), Ogata et al.
Grinnell, et al., "Trans-Activated Expression of Fully Gamma-Carboxylated Recombinant Human Protein C, An Antithrombotic Factor", Bio/Technology, 5:1189-1192, 1987.
Carlson Andrew David
Sheliga Theodore Arsay
Barrett Brian P.
Caltrider Steve
Eli Lilly and Company
Norman Doug
Weber Jon P.
LandOfFree
Activated protein C formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activated protein C formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activated protein C formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-213532